Clinical trialsRegistry-verifiedDesignated-centers model

Uniwersyteckie Centrum Kliniczne (UCK) — Klinika Psychiatrii

Gdańsk, Poland

Treatment & access

Treatments offeredLSD (MM120: clinical trial)
Access routeTrial
Cost & coverage (registry status)Free within clinical trial
Websitehttps://uck.pl

Related listings

These records belong to the same organisation. They are listed separately because each is a distinct programme or location.

Another programme at this clinicUCK : Clinical trials

About this provider

Compiled from the registry data on this page.

Uniwersyteckie Centrum Kliniczne (UCK). Klinika Psychiatrii in Gdańsk, Poland, is listed as a site of the Panorama study, a Phase 3 clinical trial of MM120 (lysergide, a pharmaceutical form of LSD) in generalized anxiety disorder, registered on ClinicalTrials.gov under NCT06809595, the registry source cited by this record. As of 2026-08-07 the registry lists the study as ACTIVE_NOT_RECRUITING: recruitment has closed and new participants can no longer join at this site. Within the trial, treatment is free of charge for enrolled participants. The record was last verified on 2026-08-07.

Services & programs

Programs & studies

Program	Kind	Status
A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (NCT06809595) Auto-linked from the record’s registry sources; status refreshed from ClinicalTrials.gov. Key entry criteria by protocol: age 18–74 · patients only (no healthy volunteers). Full inclusion and exclusion criteria on the registry. The research team makes the final eligibility decision.	clinical trial	Active Not Recruiting

1 more verified providers within 50 km

Rumia · 26 kmNiepubliczny Zakład Opieki Zdrowotnej Nr 1 Katarzyna Szalewska : Spravato®

See them on the provider map →

Common questions

What does treatment cost at Uniwersyteckie Centrum Kliniczne (UCK) — Klinika Psychiatrii?

Free within clinical trial As published by the provider (verified 2026-08-07).

Is treatment at Uniwersyteckie Centrum Kliniczne (UCK) — Klinika Psychiatrii covered by insurance?

MM120 (lysergide) Phase 3 Panorama study in generalized anxiety disorder. Registry status 2026-08-07: ACTIVE_NOT_RECRUITING - recruitment closed (EU recruitment ended 2026-05-15); do not route patients. (Verified 2026-08-07.)

Verification

License / registryCTIS (EU Clinical Trials Information System)
Official registryhttps://euclinicaltrials.eu/ctis-public/view/2024-513572-17-00
Official registryhttps://clinicaltrials.gov/study/NCT06809595
Provider websitehttps://uck.pl
Last verified2026-08-07

Re-checked every 90 days · how we verify and report corrections

Check your fit & enquire

Check my fit & enquire

Free 2-minute pre-screening in your browser · your summary goes only to Uniwersyteckie Centrum Kliniczne (UCK) — Klinika Psychiatrii, with your consent.

What to prepare before you enquire

A referral or the contact details of your treating clinician
A list of medications you have tried (names, doses, duration)
A short diagnosis summary or discharge letters

The research team confirms eligibility against your medical records at a screening visit.

Send documents directly to the provider when they reply. We never ask you to upload medical records.

Check my fit & enquire